CPA
CSBR icon

Cowen Prime Advisors’s Champions Oncology CSBR Stock Holding History

Cowen Prime Advisors’s Portfolio CSBR Stock Details CSBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-13,500
Closed -$153K – 168
2021
Q1 		$153K Hold
13,500
– – 0.06% 85
2020
Q4 		$146K Hold
13,500
– – 0.06% 79
2020
Q3 		$125K Buy
+13,500
New +$120K 0.06% 88
2020
Q2 		– Sell
-299,400
Closed -$2.22M – 184
2020
Q1 		$2.22M Buy
299,400
+145,900
+95% +$1.02M 1.35% 18
2019
Q4 		$1.28M Buy
+153,500
New +$948K 0.58% 38

Other funds holding CSBR

BMC
Battery Management Corp Boston, Massachusetts $426M AUM 21.5% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MAG
Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Cowen Prime Advisors's CSBR Position: Q2 2021 in Review

Cowen Prime Advisors sold out of Champions Oncology (CSBR) in Q2 2021, closing a stake of 13,500 shares — an estimated $153K sold.

Cowen Prime Advisors first reported a position in CSBR in Q4 2019 and held it in 5 quarters. The position peaked at $2.22M in Q1 2020. 38 funds tracked by Wall St. Rank hold CSBR as of Q2 2021.

  • Cowen Prime Advisors reported no remaining Champions Oncology position as of Q2 2021 after selling out during the quarter.
  • Cowen Prime Advisors sold 13,500 Champions Oncology shares in Q2 2021, an estimated $153K.
  • Cowen Prime Advisors first reported a position in Champions Oncology in Q4 2019 and held it in 5 quarters.
  • Cowen Prime Advisors's Champions Oncology position peaked at $2.22M in Q1 2020.
  • 38 funds tracked by Wall St. Rank held Champions Oncology as of Q2 2021.

Based on Cowen Prime Advisors's 13F filing for Q2 2021, filed 16 Jul 2021.